Taken together, all data suggest that the protease KLK12 would play a pro-tumorigenic role in breast cancer whereas KLK12vs3 (encoding a truncated protein lacking a functional catalytic triad) would have a tumor suppressor role. This evidence concerns the gene KLK12 and breast carcinoma.